Management of Rash from Zepbound Injection
Causes of Zepbound Injection Rash
- Infusion-related reactions are common with injectable medications and can manifest as rash, flushing, pruritus, and other skin manifestations in patients receiving Zepbound injection 1, 2
- These reactions may be immune-mediated or non-immune-mediated, with most being mild to moderate in severity, affecting patients treated with Zepbound 3, 4
- The rash is typically part of a constellation of symptoms that can include flushing, urticaria, pruritus, and other dermatological manifestations in individuals receiving Zepbound injection 5, 6
Prevention Strategies
- Administering premedication 30 minutes to 1 hour before Zepbound injection can reduce the risk of infusion-related reactions in patients 7, 8
- Recommended premedication regimen includes oral or IV antihistamines, such as diphenhydramine 25-50mg or cetirizine 10mg, for patients receiving Zepbound injection 9, 10
Administration Techniques
- Slow infusion rate for the first dose can minimize the risk of reaction in patients receiving Zepbound injection 4, 5
- Subsequent doses can be administered at a regular rate if no reactions occur in patients treated with Zepbound 6, 7
Management of Reactions
- For mild to moderate reactions, stop or slow the infusion rate immediately and provide symptomatic treatment, including antihistamines and topical corticosteroids, for patients experiencing reactions to Zepbound injection 1, 2
- Once symptoms resolve, the infusion may be restarted at a slower rate in patients receiving Zepbound 3, 4
- For severe reactions, stop the infusion immediately, provide aggressive symptomatic treatment, and consider permanently discontinuing the medication for patients experiencing severe reactions to Zepbound injection 1, 2, 3, 4, 5